zydus cadila covid vaccine

The vaccine is a three-dose one administered intradermally using the painless PharmaJet, a needle-free system, Tropis, on Day 0, Day 28 and Day 56. Zydus Cadila on Wednesday announced that…

According to Patel, Zydus Cadila had invested Rs 500 crore in developing the vaccine and in the manufacturing capacity with further investments expected as manufacturing capacity was being…

The Phase 3 trials on more than 28,000 volunteers across 50 clinical sites, have shown an efficacy rate of 66.6%. That is lower than the efficacy levels of vaccines from Moderna and…